Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
1 competitor in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
View Full LandscapeTarget Indication
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Clinical Trial
NCT05676203Last updated: 8/18/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Acute Coronary Syndrome
Overactive Bladder
Pneumonia, Bacterial
Chronic Kidney Disease
Colorectal Neoplasms